An interpretable artificial intelligence system for measuring the size of small polyps (< 10 mm) [0.03%]
一种可解释的人工智能系统，用于测量小型息肉（＜10毫米）的大小
Yong Li,Fujun Li,Guanghui Lian et al.
Yong Li et al.
Background: Precise polyp size measurement is vital for treatment and follow-up strategy determination, with small polyps (
Incidence and risk factors for diabetic ketoacidosis in hypertriglyceridemia-induced acute pancreatitis patients ‒ A retrospective study [0.03%]
高甘油三酯血症诱发急性胰腺炎患者糖尿病酮症酸中毒的发病及危险因素分析-一项回顾性研究
Wei Wei,Fukun Shi,Jiaxu Liang et al.
Wei Wei et al.
Background and aims: The occurrence of diabetic ketoacidosis (DKA), along with its risk factors and pathophysiological mechanisms, remains incompletely understood, this study aimed to evaluate the clinical features of DKA...
Meckel diverticulum with combined pancreatic and gastric heterotopia ‒ Its significance, clinical and pathologic presentations and literature review [0.03%]
合并有胰和胃异位组织的梅克尔憩室的意义、临床及病理表现和文献综述
Payam S Pahlavan
Payam S Pahlavan
This manuscript explores the rare occurrence of Meckel diverticulum (MD) with combined pancreatic and gastric heterotopia, a condition often associated with significant clinical symptoms and complications despite the typically asymptomatic ...
Predictors of inadequate bowel cleansing in colon capsule endoscopy: a single-center retrospective study [0.03%]
结肠胶囊内镜肠道清洁度不佳的影响因素分析——单中心回顾性研究
Ana Isabel Ferreira,Mariana Marques Souto,Tiago Lima Capela et al.
Ana Isabel Ferreira et al.
Introduction: The rate of adequate bowel preparation and complete examinations are crucial quality measures in colon capsule endoscopy (CCE). The aim of this study was to evaluate clinical and demographic factors possibly...
Risk factors associated with recurrent ischemic colitis ‒ A 10-year retrospective study [0.03%]
与缺血性结肠炎复发相关的危险因素‒10年回顾研究
Luís Relvas,Isabel Carvalho,Pedro Baltazar et al.
Luís Relvas et al.
Background: Recurrent ischemic colitis (IC) is uncommon but clinically relevant, and its risk factors remain poorly defined. We aimed to assess the prevalence of recurrence and identify associated clinical predictors. ...
One-liter polyethylene glycol with ascorbic acid provides comparable cleansing quality to two-liter regimen in bowel preparation for patients with inactive ulcerative colitis ‒ A randomized, multicenter, single-blind trial [0.03%]
一项随机、多中心、单盲试验：对于病情缓解的溃疡性结肠炎患者，1升聚乙二醇联合维生素C的肠道准备方案与2升聚乙二醇方案具有相似的清肠效果
Ji Min Lee,Kang-Moon Lee,Sung Jae Shin et al.
Ji Min Lee et al.
Introduction: Patient-centered care for ulcerative colitis (UC) involves reducing the burden associated with colonoscopy, particularly bowel preparation. Although low-volume preparations have become common in the general ...
Amber-red color imaging in third-space endoscopy and ESD: preliminary Western experience [0.03%]
第三空间内镜及ESD的琥珀红光影像：初步西方经验
Pedro Filipe Mesquita,Catarina Costa,Pedro Teixeira et al.
Pedro Filipe Mesquita et al.
ACI rendered the submucosa light blue, clearly separated from pale-pink mucosa and white muscularis, improving plane recognition and spatial orientation (notably during entry, tunnel expansion, and myotomy). ACI displayed subtle and deeper ...
Low biopsy rates and proton pump inhibitors use limit detection of eosinophilic esophagitis in Mexican patients with dysphagia [0.03%]
低活检率和质子泵抑制剂的使用限制了墨西哥吞咽困难患者嗜酸细胞性食管炎的检测
Josealberto Sebastiano Arenas-Martínez,Evan S Dellon,Orlando Emmanuel Falcón-Antonio et al.
Josealberto Sebastiano Arenas-Martínez et al.
Introduction: Eosinophilic esophagitis is a chronic, immune-mediated inflammatory disorder increasingly recognized worldwide, but its prevalence in Hispanic populations, particularly in Mexico, remains poorly characterize...
Evolving patterns and cohort-specific risks of anal cancer mortality in Spain [0.03%]
西班牙肛癌死亡率的演变模式和特定队列的风险
Lucía Cayuela,Victoria Achaval,Gema Flox-Benítez et al.
Lucía Cayuela et al.
Background: Anal cancer, though rare, is rising in high-income countries, yet long-term national data from Spain remain limited. This study evaluates 25-year trends and cohort-specific mortality risks. ...
Post-ERCP bowel evisceration in a liver transplant recipient previously treated with atezolizumab-bevacizumab: first report [0.03%]
接受阿特朱单抗-苯妥珠单抗治疗的肝移植受者的内镜逆行胰胆管造影后肠管外翻：首报病例报告
Elena Santos-Pérez,Cecile Gomercic,Maxime Thobois et al.
Elena Santos-Pérez et al.
Hepatocellular carcinoma (HCC) treatment increasingly involves liver transplantation (LT), often after downstaging therapies. Atezolizumab, a PD-L1 inhibitor, combined with bevacizumab, an anti-VEGF agent, is widely used, showing high respo...